CHI3L1 and myeloid sarcoma: The high expression of CHI3L1 in the CSF of patients with progressive MS26 may be related to the increasing number of a specific subtype of chronic active lesions, and we may speculate that its level in the CSF of patients with progressive MS may even reflect the number of this lesion type in the brain.